{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:11:45Z","timestamp":1791295905375,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jneuroim.2008.02.008","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T17:25:54Z","timestamp":1208453154000},"page":"124-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Interleukin-17 in transverse myelitis and multiple sclerosis"],"prefix":"10.1016","volume":"196","author":[{"given":"Jerome J.","family":"Graber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Rameeza","family":"Allie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina V.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam I.","family":"Kaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.02.008_bib1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin 23 promotes a distinct CD4+ T cell activation state characterized by the production of interleukin 17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1189\/jlb.0704385","article-title":"Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility","volume":"76","author":"Andersson","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib4","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1073\/pnas.90.21.10061","article-title":"Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6","volume":"90","author":"Campbell","year":"1993","journal-title":"PNAS"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib5","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1074\/jbc.M209381200","article-title":"Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant site via axonal transport","volume":"278","author":"Chauhan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/glia.1087","article-title":"Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors","volume":"35","author":"Colombatti","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1471-4159.2005.03368.x","article-title":"Astrocytes as antigen-presenting cells: expression of IL-12\/IL-23","volume":"95","author":"Constantinescu","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interluekin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib9","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000188896.48308.26","article-title":"Idiopathic acute transverse myelitis: application of the recent diagnostic criteria","volume":"65","author":"de Seze","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib10","doi-asserted-by":"crossref","first-page":"14903","DOI":"10.1073\/pnas.95.25.14903","article-title":"In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen","volume":"95","author":"Drakesmith","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib11","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1099\/vir.0.79921-0","article-title":"Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells","volume":"85","author":"Duc Dodon","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib12","doi-asserted-by":"crossref","unstructured":"Frohman, E.M., Racke, M.K., Raine, C.S., Multiple sclerosis \u2013 the plaque and its pathogenesis. N. Engl. J. Med.;354:942\u2013955.","DOI":"10.1056\/NEJMra052130"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/BF03401894","article-title":"Administration of neutralizing antibodies to interleukin-6 reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation","volume":"1","author":"Gijbels","year":"1995","journal-title":"Mol. Med."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1615\/CritRevImmunol.v24.i2.20","article-title":"Role of the IL-12\/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination","volume":"23","author":"Gran","year":"2004","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm1197","article-title":"Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis","volume":"11","author":"Greter","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin-17-producing CD4+ effect T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","article-title":"Expanding the effector CD4 T-cell repertoire: the Th17 lineage","volume":"18","author":"Harrington","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm1177","article-title":"Experimental autoimmune encephalomyelitis repressed by microglial paralysis","volume":"11","author":"Heppner","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib19","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.4049\/jimmunol.136.9.3239","article-title":"Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain","volume":"136","author":"Hofman","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/0891693031000089427","article-title":"Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission","volume":"36","author":"Hollifield","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib21","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/ard.2004.024737","article-title":"Anti-tumor necrosis factor-alpha therapy for rheumatoid arthritis: an update on safety","volume":"63","author":"Hyrich","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib22","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.165.11.6107","article-title":"Microbial lipopeptides induce the production of IL-17 in Th cells","volume":"165","author":"Infante-Duarte","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/brain\/awh453","article-title":"Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis","volume":"128","author":"Ishizu","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/glia.20109","article-title":"IL-1-regulated responses in astrocytes: relevance to injury and recovery","volume":"49","author":"John","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib25","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib26","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI25141","article-title":"Interleukin 6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis","volume":"10","author":"Kaplin","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00019052-200206000-00019","article-title":"Immunopathogenesis of acute transverse myelitis","volume":"15","author":"Kerr","year":"2002","journal-title":"Curr Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib30","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-\u03b2 induces development of the Th17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interluekin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.imlet.2004.04.018","article-title":"Soluble interleukin-6 receptor in cerebrospinal fluid of patients with inflammatory and non-inflammatory neurologic diseases","volume":"94","author":"Michalopoulou","year":"2004","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1468-1331.2002.00437.x","article-title":"Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients","volume":"9","author":"Miljkovic","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/intimm\/10.5.703","article-title":"IL-6 deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein","volume":"10","author":"Okuda","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib37","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4049\/jimmunol.173.6.3844","article-title":"IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation","volume":"173","author":"Park","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib38","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/135245859800400314","article-title":"Monocyte activation in multiple sclerosis","volume":"4","author":"Reder","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJM199108153250704","article-title":"Assocation between tumor necrosis factor-\u03b1 and disease progression in multiple sclerosis","volume":"325","author":"Sharief","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.10519","article-title":"Interleukine-1\u03b2 promotes oligodendrocyte death through glutamate excitotoxicity","volume":"53","author":"Takahashi","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/glia.1088","article-title":"Continuous interleukin-6 application in vivo via macroencapsulation of interleukin-6-expressing COS-7 cells induces massive gliosis","volume":"35","author":"Tilgner","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib44","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI and clinical activity in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"Van Oosten","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(99)00187-3","article-title":"Interleukin-6 expression and regulation in astrocytes","volume":"100","author":"Van Wagoner","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib46","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1523\/JNEUROSCI.19-13-05236.1999","article-title":"Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor","volume":"19","author":"Van Wagoner","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2008.02.008_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF-\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00063030-200216030-00003","article-title":"Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials","volume":"16","author":"Wiendl","year":"2002","journal-title":"BioDrugs"},{"key":"10.1016\/j.jneuroim.2008.02.008_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","article-title":"IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses","volume":"101","author":"Xing","year":"1998","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:08:08Z","timestamp":1759046888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":49,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0165572808000398"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.02.008","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-17 in transverse myelitis and multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}